Preliminary programme

SATURDAY 6 MARCH 

Virtual meeting

9:00 – 9:05

BMUC opening and welcome

Thierry Roumeguère

 9:05 – 9:30

Renal Cell Carcinoma (RCC)

Moderators: Maarten Albersen – Sylvie Rottey – Nora Sundahl

9:05 – Metastasis-directed therapy for oligometastatic RCC in the immunotherapy era

Shankar Siva 

09:20 – Q&A

9:30 – 9:40

Research grant

Thierry Roumeguère

9:40 – 9:50

Coffee break

  9:50 – 11:05

Prostate cancer

Moderators: Piet Dirix – Wouter Everaerts – Karolien Goffin

9:50 – Biomarker driven prostate cancer care: when prognostic biomarkers surpass predictive biomarkers 

Daniel E. Spratt

10:10 – Q&A

10:20 – Practical issues of next generation sequencing in prostate cancer 

Robin de Putter 

10:30 – Q&A

10:35 – Optimum imaging strategies for advanced prostate cancer: ASCO guideline 

Anwar Padhani 

10:55 – Q&A

11:05 – 11:15

Coffee break

  11:15 – 12:10

Bladder cancer

Moderators: Jean-Pascal Machiels – Thierry Roumeguère

Bladder preservation in muscle invasive bladder cancer

11:15 – Radiochemotherapy / radioimmunotherapy

Nora Sundahl

11:25 – Is neoadjuvant immunotherapy good enough? 

Nieves Martinez-Chanza

11:35 – Yes / maybe we still need cystectomy

Jim Catto 

11:45 – Q&A

12:00 – New molecules in bladder cancer 

Marco Gizzi 

12:10 – 12:20

Coffee break

 12:20 – 12:45

Testicular cancer 

Moderators: Karolien Goffin – Benjamin Ledoux – Brieuc Sautois

12:20 – Follow up of early testicular cancer: when and how long? 

Robert Huddart 

12:35 – Q&A

12:45 – 13:00

               Take home messages

                     Sylvie Rottey

 13:00

                  End of the meeting

RIZIV/INAMI and FANC accreditation points have been applied for.